Recent Posts
- CV6 Therapeutics to Attend JP Morgan Week
- CV6 Receives MHRA Approval for Novel Cancer Therapy Phase 1a Clinical Trial
- CV6 CEO Co-authors Study on Cancer Care in Ireland
- CV6 CEO Presents at ‘Agreement 25: Cancer Knows no Borders’
- CV6 Therapeutics Secures $9.2m to Progress Novel Cancer Drug to Phase 1a Trial